[1]李 贺,付 锐,孙远松,等.早期区域动脉灌注肝素治疗高脂血症性SAP的临床效果[J].医学信息,2019,32(10):99-101.[doi:10.3969/j.issn.1006-1959.2019.10.031]
　LI He,FU Rui,SUN Yuan-song,et al.Clinical Effect of Early Regional Arterial Infusion of Heparin inthe Treatment of SAP with Hyperlipidemia[J].Journal of Medical Information,2019,32(10):99-101.[doi:10.3969/j.issn.1006-1959.2019.10.031]
点击复制

早期区域动脉灌注肝素治疗高脂血症性SAP的临床效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年10期
页码:
99-101
栏目:
临床研究
出版日期:
2019-05-15

文章信息/Info

Title:
Clinical Effect of Early Regional Arterial Infusion of Heparin inthe Treatment of SAP with Hyperlipidemia
文章编号:
1006-1959（2019）10-0099-03
作者:
李 贺; 付 锐; 孙远松; 尹纯林; 汪海平; 王召华; 闵 安; 李申涛
（安徽医科大学第二附属医院急诊外科，安徽 合肥 230601）
Author(s):
LI He; FU Rui; SUN Yuan-song; YIN Chun-lin; WANG Hai-ping; WANG Zhao-hua; MIN An; LI Shen-tao
(Department of Emergency Surgery,Second Affiliated Hospital of Anhui Medical University,Hefei 230601,Anhui,China)
关键词:
高脂血症; 重症急性胰腺炎; CRAI; 肝素
Keywords:
Hyperlipidemia; Severe acute pancreatitis; CRAI; Heparin
分类号:
R576
DOI:
10.3969/j.issn.1006-1959.2019.10.031
文献标志码:
A
摘要:
目的 探讨高脂血症性重症急性胰腺炎患者使用早期区域动脉灌注肝素的治疗效果，为改善患者预后提供新的治疗依据。方法 收集我院急诊外科2015年7月~2017年6月收治的符合纳入、排除标准的重症急性胰腺炎患者51例，随机分组为普通治疗组（23例）及CRAI组（28例），普通治疗组按胰腺炎常规治疗方法治疗，CRAI组通过股动脉置管，持续泵入低分子肝素，比较两组的临床治疗效果及血液学指标等情况。结果 CRAI组的胰腺坏死率、胰周感染率、死亡率分别为10.71%、21.43%、7.14%，均低于普通治疗组的43.48%、56.52%、39.13%，差异具有统计学意义（P＜0.05）；CRAI组患者的住院时间、ICU住院时间、血管活性药物使用时间分别为（15.22±3.71）d、（6.94±1.23）d、（4.57±1.02）d，均低于普通治疗组的（40.34±4.47）d、（20.44±2.15）d、（17.84±3.33）d，差异具有统计学意义（P＜0.05）；CRAI组患者血清甘油三酯水平较普通治疗组下降，差异具有统计学意义（P＜0.05）；两组APTT比较，差异无统计学意义（P＞0.05）。结论 CRAI治疗高脂血症性重症急性胰腺炎的临床效果更好，可降低患者胰腺坏死率、胰周感染率及死亡率，缩短患者住院时间，且不影响患者的凝血功能，安全可靠。
Abstract:
Objective To investigate the therapeutic effect of early regional arterial infusion of heparin in patients with severe acute pancreatitis with hyperlipidemia, and to provide a new therapeutic basis for improving the prognosis of patients.Methods A total of 51 patients with severe acute pancreatitis who met the inclusion and exclusion criteria from July 2015 to June 2017 in our hospital were randomly divided into the general treatment group (23 cases) and the CRAI group (28 cases). The treatment group was treated according to the conventional treatment of pancreatitis. The CRAI group was placed in the femoral artery and the low molecular weight heparin was continuously pumped. The clinical treatment effect and hematological parameters of the two groups were compared.Results The pancreatic necrosis rate, peripancreatic infection rate and mortality rate in the CRAI group were 10.71%, 21.43%, and 7.14%, respectively, which were lower than the 43.48%, 56.52%, and 39.13% of the general treatment group,the difference was statistically significant (P<0.05); hospitalization time, ICU hospitalization time, and vasoactive drug use time in CRAI group were (15.22±3.71)d, (6.94±1.23)d, (4.57±1.02)d, respectively, which were lower than those of the general treatment group ( 40.34±4.47)d, (20.44±2.15)d, (17.84±3.33)d, the difference was statistically significant (P<0.05). The serum triglyceride level in the CRAI group was lower than that in the normal treatment group,the difference was statistically significant(P<0.05); There was no significant difference in APTT between the two groups (P>0.05).Conclusion CRAI is effective in the treatment of severe acute pancreatitis with hyperlipidemia. It can reduce pancreatic necrosis rate, peripancreatic infection rate and mortality, shorten the hospital stay, and not affect the patient's coagulation function. It is safe and reliable.

参考文献/References:

[1]Ji T,Li X,Zhang X,Hui L,et al.Evaluation of the Severity of Hyperlipidemia Pancreatitis Using CT-measured Visceral Adipose Tissue[J].J Clin Gastroenterol,2018.
[2]Zhu F,Guan Y,Zhang R.Inhibition of JAK2 signaling alleviates hyperlipidemia-intensified caerulin-induced acute pancreatitis in vivo[J].Curr Mol Med,2017,17(5):381-387.
[3]吕贺贺,项和平,王伟,等.早期区域动脉灌注微量低分子肝素改善高脂血症性急性胰腺炎微循环的实验研究[J].安徽医科大学学报,2018,53(2):226-231.
[4]黄桔秀,章赛军,阮潇潇,等.高脂血症性及非高脂血症性急性胰腺炎患者的临床特点与C-反应蛋白对其严重程度的评估[J].中华医院感染学杂志,2018,28(6):893-895,903.
[5]Dumnicka P,Maduzia D,Ceranowicz P,et al.The Interplay between Inflammation, Coagulation and Endothelial Injury in the Early Phase of Acute Pancreatitis:Clinical Implications[J].Int J Mol Sci,2017,18(2):354.
[6]Ke L,Ni HB,Tong ZH,et al.Efficacy of continuous regional arterial infusion with low-molecular-weight heparin for severe acute pancreatitis in a porcine model[J].Shock,2014,41(5):443-448.
[7]Yamamoto T,Yamamura H,Yamamoto H,et al.Comparison of the efficacy of continuous i.v. infusion versus continuous regional arterial infusion of nafamostat mesylate for severe acute pancreatitis[J].Acute Med Surg,2016,3(3):237-243.
[8]Yong FJ,Mao XY,Deng LH,et al.Continuous regional arterial infusion for the treatment of severe acute pancreatitis:a meta-analysis[J].Hepatobiliary Pancreat Dis Int,2015,14(1):10-17.
[9]Deng ZG,Zhou JY,Yin ZY,et al.Continuous regional arterial infusion and laparotomic decompression for severe acute pancreatitis with abdominal compartment syndrome[J].World Journal of Gastroenterology,2011,17(44):4911-4916.
[10]侯敬,李斯宁,梁爽,等.6-KPGF1α、TXB2在硫酸镁联合低分子肝素治疗子痫前期中的作用和意义[J].国际检验医学杂志,2018,39(23):2971-2974.
[11]DU JD,Zheng X,Huang ZQ,et al.Effects of intensive insulin therapy combined with low molecular weight heparin anticoagulant therapy on severe pancreatitis[J].Exp Ther Med,2014,8(1):141-146.

相似文献/References:

[1]车鹏博,阮继刚,郭 丹.红细胞分布宽度联合D-二聚体含量预测 急性胰腺炎严重程度的价值[J].医学信息,2018,31(12):73.[doi:10.3969/j.issn.1006-1959.2018.12.022]
　CHE Peng-bo,RUAN Ji-gang,GUO Dan.The Value of Red Blood Cell Distribution Width Combined with D-dimer Content in Predicting the Severity of Acute Pancreatitis[J].Journal of Medical Information,2018,31(10):73.[doi:10.3969/j.issn.1006-1959.2018.12.022]
[2]刘 云,于洪波.乌司他丁与生长抑素治疗重症急性胰腺炎临床疗效观察[J].医学信息,2019,32(01):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
　LIU Yun,YU Hong-bo.Clinical Efficacy of Ulinastatin and Somatostatin in the Treatment of Severe Acute Pancreatitis[J].Journal of Medical Information,2019,32(10):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
[3]杨 雍,吕汝琦,刘 丹.早期无创正压通气对重症急性胰腺炎合并肺损伤的保护作用机制[J].医学信息,2019,32(03):55.[doi:10.3969/j.issn.1006-1959.2019.03.018]
　YANG Yong,LV Ru-qi,LIU Dan.Protective Mechanism of Early Noninvasive Positive Pressure Ventilation on Severe Acute Pancreatitis Complicated with Lung Injury[J].Journal of Medical Information,2019,32(10):55.[doi:10.3969/j.issn.1006-1959.2019.03.018]
[4]金玉珍,封海霞.CRRT治疗高脂血症性急性胰腺炎的容量管理研究[J].医学信息,2019,32(15):101.[doi:10.3969/j.issn.1006-1959.2019.15.032]
　JIN Yu-zhen,FENG Hai-xia.Capacity Management of CRRT in the Treatment of Hyperlipidemic Acute Pancreatitis[J].Journal of Medical Information,2019,32(10):101.[doi:10.3969/j.issn.1006-1959.2019.15.032]
[5]陈智华.赤芍加清胰汤联合空肠营养治疗重症急性胰腺炎的临床效果[J].医学信息,2019,32(21):156.[doi:10.3969/j.issn.1006-1959.2019.21.052]
　CHEN Zhi-hua.Clinical Observation on Treatment of Severe Acute Pancreatitis with Chishao Plus Qingyi Decoction Combined with Jejunal Nutrition[J].Journal of Medical Information,2019,32(10):156.[doi:10.3969/j.issn.1006-1959.2019.21.052]
[6]付满玲,黄雨佳,刘珉甬,等.山楂代用茶对大鼠经口急性毒性实验[J].医学信息,2020,33(01):77.[doi:10.3969/j.issn.1006-1959.2020.01.024]
　FU Man-ling,HUANG Yu-jia,LIU Min-yong,et al.Experimental on Oral Acute Toxicity of Hawthorn Substitute Tea on Rats[J].Journal of Medical Information,2020,33(10):77.[doi:10.3969/j.issn.1006-1959.2020.01.024]
[7]曹绪深.稳心调脂汤对冠心病合并高脂血症患者中医证候及血脂水平的影响[J].医学信息,2020,33(07):160.[doi:10.3969/j.issn.1006-1959.2020.07.053]
　CAO Xu-shen.Effect of Wenxin Tiaozhi Decoction on TCM Syndromes and Blood Lipid Levels in Patients with Coronary Heart Disease and Hyperlipidemia[J].Journal of Medical Information,2020,33(10):160.[doi:10.3969/j.issn.1006-1959.2020.07.053]
[8]罗冬梅,马立萍,高绪霞,等.北京多社区卫生服务中心老年患者处方降脂药物合理应用分析[J].医学信息,2020,33(18):127.[doi:10.3969/j.issn.1006-1959.2020.18.041]
　LUO Dong-mei,MA Li-ping,GAO Xu-xia,et al.Analysis of Rational Application of Lipid-lowering Drugs Prescribed by Elderly Patients in Beijing Multi-community Health Service Centers[J].Journal of Medical Information,2020,33(10):127.[doi:10.3969/j.issn.1006-1959.2020.18.041]
[9]农美丹,王晓迪,莫永华,等.不同性别早发冠心病患者的心血管危险因素分析[J].医学信息,2021,34(08):95.[doi:10.3969/j.issn.1006-1959.2021.08.024]
　NONG Mei-dan,WANG Xiao-di,MO Yong-hua,et al.Analysis of Cardiovascular Risk Factors in Patients with Premature Coronary Heart Disease of Different Genders[J].Journal of Medical Information,2021,34(10):95.[doi:10.3969/j.issn.1006-1959.2021.08.024]
[10]冯维静,许程飞.零缺陷护理干预在连续性血液净化治疗重症急性胰腺炎中的应用[J].医学信息,2021,34(08):186.[doi:10.3969/j.issn.1006-1959.2021.08.052]
　FENG Wei-jing,XU Cheng-fei.Application of Zero Defect Nursing Intervention in Continuous Blood Purification Treatment of Severe Acute Pancreatitis[J].Journal of Medical Information,2021,34(10):186.[doi:10.3969/j.issn.1006-1959.2021.08.052]

更新日期/Last Update: 2019-05-15